More articles from Poster Presentations - Nuclear Oncogenes and Tumor Suppressors

Abstract 2567: CYP24A1-induced vitamin D insufficiency promotes breast cancer growth
Makoto Osanai, Akira Takasawa, Kumi Takasawa, Masaki Murata, Norimasa Sawada

Cancer Research Jul 2017, 77 (13 Supplement) 2567; DOI: 10.1158/1538-7445.AM2017-2567
Abstract 2579: Identifying pathways that regulate the turnover of gain-of-function p53 mutant proteins in ovarian cancer cells
Achuth Padmanabhan, Nicholes Candelaria, Kwong-Kwok Wong, Bryan C. Nikolai, David Lonard, Bert W. O'Malley, JoAnne S. Richards

Cancer Research Jul 2017, 77 (13 Supplement) 2579; DOI: 10.1158/1538-7445.AM2017-2579
Abstract 2562: Stromal antigen 1 (SA1) as a potential pro-neoplastic factor in non-small-cell lung cancer (NSCLC)
Michelle Zhang, Mart Dela Cruz, Navneet Momi, Sanjib Chowdhury, Hemant Roy, Adam Lerner

Cancer Research Jul 2017, 77 (13 Supplement) 2562; DOI: 10.1158/1538-7445.AM2017-2562
Abstract 2565: VCP/p97 segregase-mediated regulation of chromatin-bound PTEN stability
Jinshan He, Gulzar Wani, Qianzheng Zhu, Altaf A Wani

Cancer Research Jul 2017, 77 (13 Supplement) 2565; DOI: 10.1158/1538-7445.AM2017-2565
Abstract 2572: The novel long non-coding RNA PANCR is an intracellular p53 activator
Yu Cao

Cancer Research Jul 2017, 77 (13 Supplement) 2572; DOI: 10.1158/1538-7445.AM2017-2572
Abstract 2566: Positive cross-regulatory loop links ZBTB7A to estrogen receptor alpha expression in breast cancer
Mary Ellen Molloy, Monika Lewinska, ThanhThao Nguyen, Zhi-Min Yuan

Cancer Research Jul 2017, 77 (13 Supplement) 2566; DOI: 10.1158/1538-7445.AM2017-2566
Abstract 2570: Induction of mild oxidative stress as a strategy for reactivation of mutant p53 proteins: KSS72, a small molecule derived from ethacrynic acid restores the biological functions of R248W/Q mutant
Surendra R. Punganuru, Hanumantha Rao Madala, Kalkunte S. Srivenugopal

Cancer Research Jul 2017, 77 (13 Supplement) 2570; DOI: 10.1158/1538-7445.AM2017-2570
Abstract 2569: BCL6 promotes glioma and serves as a novel therapeutic target
Liang Xu, Ye CHEN, Marina Dutra-Clarke, Anand Mayakonda, Masaharu Hazawa, Steve E. Savinoff, Ngan Doan, Jonathan W. Said, William H. Yong, Henry Yang, Ling-Wen Ding, Yan-Yi Jiang, Jeffrey W. Tyner, Jianhong Ching, Jean-Paul Kovalik, Markus Müschen, Joshua J. Breunig, De-Chen Lin, Phillip Koeffler

Cancer Research Jul 2017, 77 (13 Supplement) 2569; DOI: 10.1158/1538-7445.AM2017-2569
Abstract 2560: Identification and characterization of EWS-FLI1 binding partners in Ewing sarcoma cell lines
Matthew L. Rotondi, Peter J. Houghton

Cancer Research Jul 2017, 77 (13 Supplement) 2560; DOI: 10.1158/1538-7445.AM2017-2560
Abstract 2574: The PICT-1 is required for USP7 to effectively stabilize p53 protein, and codon 389 polymorphism is a risk factor for ovarian cancer
Masafumi Yoshimoto, Aoi Tokuda, Yuji Yaginuma

Cancer Research Jul 2017, 77 (13 Supplement) 2574; DOI: 10.1158/1538-7445.AM2017-2574

Main menu

User menu

Search

More articles from Poster Presentations - Nuclear Oncogenes and Tumor Suppressors

Pages

Articles

Info for

About Cancer Research